Mutations in RAC1 P29, the third most frequently mutated codon in human cutaneous melanoma, can activate the PAK, AKT and ARF/MRTF signaling pathways and lead to melanocytic mesenchymal phenotypic switching39. This evidence concerns the gene CDKN2A and cutaneous melanoma.